🔗 Permalink

Inventor profile of:

John T. Isaacs

City:

Phoenix, Maryland

Country:

United States

Published Applications:

Last publication date:

2025-09-11

Top Assignees for applications by John T. Isaacs

The entities that hold a legal rights for patent applications filed by inventor Isaacs John T.:

THE JOHNS HOPKINS UNIVERSITY 4 Baltimore, MD United States
GENSPERA, INC. 2 SAN ANTONIO, TX United States
UNIVERSITY OF VICTORIA INNOVATION AND DEVELOPMENT CORPORATION 2 Victoria, BC Canada
University of Victoria Innovatiion and Development Corporation 1 Victoria, BC, Canada
JOHNS HOPKINS UNIVERSITY 1 Baltimore, MD United States

Recent patent applications by Isaacs John T.

John T. Isaacs from Phoenix, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-11

US20250281509A1

Human necessities

SEQUENTIAL HORMONE THERAPY TO IMPROVE SURVIVAL AND ENHANCE RESPONSE TO IMMUNE THERAPY IN MEN WITH PROSTATE CANCER

#2 | 2021-07-08

US20210205408A1

Human necessities

ALBUMIN-PROAEROLYSIN PRODRUGS

#3 | 2020-08-27

US20200268836A1

Human necessities

Albumin-proaerolysin prodrugs

#4 | 2018-05-31

US20180148480A1

Chemistry; metallurgy

SYNTHETIC ENHANCEMENT OF THE T-CELL ARMAMENTARIUM AS AN ANTI-CANCER THERAPY

#5 | 2018-01-11

US20180008668A1

Human necessities

Albumin-proaerolysin prodrugs

#6 | 2012-10-25

US20120270768A1

Human necessities

Tumor activated prodrugs

#7 | 2012-10-25

US20120270767A1

Human necessities

Tumor activated prodrugs

#8 | 2010-09-16

US20100234300A1

Human necessities

Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer

#9 | 2010-05-13

US20100120697A1

Human necessities

Tumor Activated Prodrugs

#10 | 2008-12-23

US10432849

Tissue specific prodrugs

#11 | 2008-04-17

US20080089869A1

Human necessities

Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer

#12 | 2007-10-16

US10487115

Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer

#13 | 2005-11-10

US20050250102A1

Physics

Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1

InventorID:

2085809 ⎘